Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · IEX Real-Time Price · USD
1.980
-0.010 (-0.50%)
At close: Jul 19, 2024, 4:00 PM
1.990
+0.010 (0.51%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Stereotaxis Revenue
Stereotaxis had revenue of $27.10M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $6.88M with 5.07% year-over-year growth. In the year 2023, Stereotaxis had annual revenue of $26.77M.
Revenue (ttm)
$27.10M
Revenue Growth
-2.01%
P/S Ratio
6.04
Revenue / Employee
$222,156
Employees
122
Market Cap
163.63M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
Dec 31, 2019 | 28.90M | -444.07K | -1.51% |
Dec 31, 2018 | 29.35M | -1.80M | -5.77% |
Dec 31, 2017 | 31.14M | -1.02M | -3.17% |
Dec 31, 2016 | 32.16M | -5.51M | -14.63% |
Dec 31, 2015 | 37.67M | 2.66M | 7.61% |
Dec 31, 2014 | 35.01M | -3.02M | -7.94% |
Dec 31, 2013 | 38.03M | -8.53M | -18.32% |
Dec 31, 2012 | 46.56M | 4.58M | 10.90% |
Dec 31, 2011 | 41.99M | -12.06M | -22.32% |
Dec 31, 2010 | 54.05M | 2.90M | 5.67% |
Dec 31, 2009 | 51.15M | 10.78M | 26.72% |
Dec 31, 2008 | 40.37M | 1.07M | 2.71% |
Dec 31, 2007 | 39.30M | 12.11M | 44.52% |
Dec 31, 2006 | 27.19M | 12.17M | 80.96% |
Dec 31, 2005 | 15.03M | -3.79M | -20.14% |
Dec 31, 2004 | 18.82M | 13.80M | 275.22% |
Dec 31, 2003 | 5.01M | 5.00M | 26,433.74% |
Dec 31, 2002 | 18.90K | - | - |
Dec 31, 2001 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
TruBridge | 336.45M |
Repare Therapeutics | 97.86M |
TriSalus Life Sciences | 21.98M |
Syros Pharmaceuticals | 6.98M |
INmune Bio | 131.00K |
STXS News
- 3 days ago - Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir - GlobeNewsWire
- 7 weeks ago - Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment - GlobeNewsWire
- 2 months ago - Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework - GlobeNewsWire
- 2 months ago - First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology - GlobeNewsWire
- 2 months ago - Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa - GlobeNewsWire
- 2 months ago - Stereotaxis Reports 2024 First Quarter Financial Results - GlobeNewsWire
- 2 months ago - Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies - GlobeNewsWire
- 3 months ago - Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire